These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 7662244)
41. [Influence of blood pressure variability during office visit on the estimation of blood pressure control in treated hypertensive patients]. Villeneuve F; Rosenbaum D; Gury C; Girerd X Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):198-202. PubMed ID: 22677179 [TBL] [Abstract][Full Text] [Related]
45. White coat hypertension and white coat effect. Similarities and differences. Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Zampi I; Gattobigio R; Sacchi N; Porcellati C Am J Hypertens; 1995 Aug; 8(8):790-8. PubMed ID: 7576395 [TBL] [Abstract][Full Text] [Related]
46. [Left ventricular hypertrophy and blood pressure values during 24-hour ambulatory monitoring and office measurements in essential hypertension]. Kabat M; Michalak E; Szaroszyk W Kardiol Pol; 1993 Apr; 38(4):249-55. PubMed ID: 8411830 [TBL] [Abstract][Full Text] [Related]
47. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial. Myers MG; Godwin M; Dawes M; Kiss A; Tobe SW; Grant FC; Kaczorowski J BMJ; 2011 Feb; 342():d286. PubMed ID: 21300709 [TBL] [Abstract][Full Text] [Related]
48. ["White-coat hypertension": variation of normality or of hypertension?]. Carmona J; Amado P; Vasconcelos N; Santos I; Pinto C; Forte G; Arsénio A; Nazaré J Rev Port Cardiol; 1998 Jun; 17(6):505-12. PubMed ID: 9677828 [TBL] [Abstract][Full Text] [Related]
49. White-coat hypertension and cardiac organ damage in elderly subjects. Rizzo V; Cicconetti P; Bianchi A; Lorido A; Morelli S; Vetta F; Salza MC; Marigliano V J Hum Hypertens; 1996 May; 10(5):293-8. PubMed ID: 8817402 [TBL] [Abstract][Full Text] [Related]
50. [Role of physician-patient dialogue in the "white-coat" effect in arterial hypertension. Reproducibility during the consultation. Existence despite of treatment]. Le Pailleur C; Landais P Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):135-8. PubMed ID: 8024225 [TBL] [Abstract][Full Text] [Related]
51. Repeated office blood pressure controls reduce the prevalence of white-coat hypertension and detect a group of white-coat normotensive patients. Fogari R; Corradi L; Zoppi A; Lusardi P; Poletti L Blood Press Monit; 1996 Feb; 1(1):51-54. PubMed ID: 10226202 [TBL] [Abstract][Full Text] [Related]
52. Sex, cardiac hypertrophy and diurnal blood pressure variations in essential hypertension. Verdecchia P; Schillaci G; Boldrini F; Guerrieri M; Porcellati C J Hypertens; 1992 Jul; 10(7):683-92. PubMed ID: 1321197 [TBL] [Abstract][Full Text] [Related]
53. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care]. Villalba Alcalá F; Lapetra Peralta J; Mayoral Sánchez E; Espino Montoro A; Cayuela Domínguez A; López Chozas JM Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850 [TBL] [Abstract][Full Text] [Related]
54. Ambulatory blood pressure measurement in the main cities of Cameroon: prevalence of masked and white coat hypertension, and influence of body mass index. Takah N; Dzudie A; Ndjebet J; Wawo G; Kamdem F; Monkam Y; Luma H; Ngu KB; Kengne AP Pan Afr Med J; 2014; 19():240. PubMed ID: 25848455 [TBL] [Abstract][Full Text] [Related]
55. Interactive action of the white-coat effect and the blood pressure levels on cardiovascular complications in hypertension. Palatini P; Penzo M; Canali C; Dorigatti F; Pessina AC Am J Med; 1997 Sep; 103(3):208-16. PubMed ID: 9316553 [TBL] [Abstract][Full Text] [Related]
56. The importance of the clinical observer in the development of a white-coat effect in African-American patients with hypertension. Labinson PT; Giacco S; Gift H; Mansoor GA; White WB Blood Press Monit; 2008 Jun; 13(3):139-42. PubMed ID: 18496287 [TBL] [Abstract][Full Text] [Related]
57. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring. Gualdiero P; Niebauer J; Addison C; Clark SJ; Coats AJ Blood Press Monit; 2000 Apr; 5(2):53-7. PubMed ID: 10828890 [TBL] [Abstract][Full Text] [Related]
58. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring. Ben-Dov IZ; Perk G; Ben-Arie L; Mekler J; Bursztyn M Am J Hypertens; 2004 Jun; 17(6):535-9. PubMed ID: 15177528 [TBL] [Abstract][Full Text] [Related]
59. Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. Little P; Barnett J; Barnsley L; Marjoram J; Fitzgerald-Barron A; Mant D BMJ; 2002 Aug; 325(7358):254. PubMed ID: 12153923 [TBL] [Abstract][Full Text] [Related]
60. White coat phenomenon in patients receiving antihypertensive therapy. Myers MG; Reeves RA Am J Hypertens; 1991 Oct; 4(10 Pt 1):844-9. PubMed ID: 1747219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]